Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-106399
Filing Date
2018-04-03
Accepted
2018-04-03 17:24:02
Documents
9
Effectiveness Date
2018-04-03

Document Format Files

Seq Description Document Type Size
1 DEFA14A d523331ddefa14a.htm DEFA14A 42391
2 GRAPHIC g523331aaaa.jpg GRAPHIC 2913
3 GRAPHIC g523331snap33.jpg GRAPHIC 5524
4 GRAPHIC g523331snap332.jpg GRAPHIC 5294
5 GRAPHIC g523331snap333.jpg GRAPHIC 5637
6 GRAPHIC g523331snap334.jpg GRAPHIC 5521
7 GRAPHIC g523331snap335.jpg GRAPHIC 2828
8 GRAPHIC g523331snap336.jpg GRAPHIC 2918
9 GRAPHIC g523331snap4.jpg GRAPHIC 2882
  Complete submission text file 0001193125-18-106399.txt   90900
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-14710 | Film No.: 18734654
SIC: 2834 Pharmaceutical Preparations